Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 139

Results For "Import"

2005 News Found

Moderna announces advancements in mRNA platform science for application across multiple diseases
Biotech | May 17, 2022

Moderna announces advancements in mRNA platform science for application across multiple diseases

Moderna continues to expand its mRNA platform for a range of additional clinical applications and routes of administration including a modality for lung delivery


University of Nebraska Medical Center and ANANDA Scientific announce USFDA approval
Biotech | May 17, 2022

University of Nebraska Medical Center and ANANDA Scientific announce USFDA approval

The study will evaluate the effectiveness of Nantheia ATL5, an investigational drug using cannabidiol in ANANDA’s proprietary delivery technology


GeneQuantum Healthcare's two bioconjugate drugs approved for clinical trials in Australia
Biotech | May 16, 2022

GeneQuantum Healthcare's two bioconjugate drugs approved for clinical trials in Australia

They are GQ1005, an ADC with an excellent bystander killing effect, and GQ1007, a first-in-class antibody-immune-agonist-conjugate (AIAC) both with global intellectual property rights


Urologists explore the role of robotics, equity, exercise and medicine on bladder cancer
Healthcare | May 16, 2022

Urologists explore the role of robotics, equity, exercise and medicine on bladder cancer

Researchers presented these bladder cancer study findings at the 117th Annual Scientific Meeting of the American Urological Association (AUA)


USFDA approves novel, dual-targeted treatment for type 2 diabetes
Drug Approval | May 15, 2022

USFDA approves novel, dual-targeted treatment for type 2 diabetes

In clinical trials, treatment proved more effective than other therapies evaluated


Merck KGaA first quarter earnings grows on higher volumes, margins
News | May 15, 2022

Merck KGaA first quarter earnings grows on higher volumes, margins

Q1 net sales increased by 12.2% to € 5,198 million compared with the year-earlier quarter


Zydus launches Bemdac to treat LDL-Cholesterol
Drug Approval | May 14, 2022

Zydus launches Bemdac to treat LDL-Cholesterol

It is a new class of drug that treats uncontrolled LDLCholesterol, despite the use of a maximum tolerated dose of statins


LOTTE to purchase Bristol Myers Squibb manufacturing facility in East Syracuse, New York
News | May 14, 2022

LOTTE to purchase Bristol Myers Squibb manufacturing facility in East Syracuse, New York

East Syracuse site to serve as the LOTTE Center for North America Operations for LOTTE’s biologics contract development and manufacturing organization (CDMO) business


Piyush Goyal invites Oman to increase pharma trade with India
News | May 13, 2022

Piyush Goyal invites Oman to increase pharma trade with India

The pharma companies will bring quality products at competitive prices to consumers in Oman and help bring down the cost of healthcare


PCI Pharma Services announces US $100 million investment in New England
Biotech | May 13, 2022

PCI Pharma Services announces US $100 million investment in New England

Capabilities include the latest in sterile lyophilization and liquid filling technology to support global pharmaceutical supply chain, keeping pace with industry trends